What's in Jiangxi Qingfeng Pharmaceutical Co. Ltd.'s pipeline?

Jiangxi Qingfeng Pharmaceutical Co. Ltd. has 14 drugs in our index: 3 marketed, 0 filed, 1 in Phase 3, 3 in Phase 2, 7 in Phase 1.

Which companies overlap with Jiangxi Qingfeng Pharmaceutical Co. Ltd.'s portfolio?

Top competitors by shared drug class: ADvantage Therapeutics, AJU Pharm Co., Ltd., AO GENERIUM, Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiangxi-qingfeng-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Jiangxi Qingfeng Pharmaceutical Co. Ltd. — Portfolio Competitive Intelligence Brief

Jiangxi Qingfeng Pharmaceutical Co. Ltd. pipeline: 3 marketed, 0 filed, 1 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 3 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
andrographolide sulfonate	andrographolide sulfonate	marketed
andrographolide sulfonate simulation	andrographolide sulfonate simulation	marketed	Natural product derivative; anti-inflammatory agent	Immunology; Infectious Disease
Standard treatment+Xiyanping injection	Standard treatment+Xiyanping injection	marketed	Traditional Chinese medicine extract	Infectious Disease / Immunology
GP681 Simulant	GP681 Simulant	phase 3	Stimulant	Attention Deficit Hyperactivity Disorder (ADHD)

Therapeutic area mix

Attention Deficit Hyperactivity Disorder (ADHD) · 1
Diabetes · 1
Immunology; Infectious Disease · 1
Infectious Disease / Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADvantage Therapeutics · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
3D Medicines (Beijing) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jiangxi Qingfeng Pharmaceutical Co. Ltd.:

Cite this brief

Drug Landscape (2026). Jiangxi Qingfeng Pharmaceutical Co. Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiangxi-qingfeng-pharmaceutical-co-ltd. Accessed 2026-05-16.